BLPH insider filings
Bellerophon Therapeutics, Inc. — 48 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-16. Screen BLPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BLPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Bellerophon Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-10-16 | 4 | Puissance Capital Management LP — 10% owner Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Wang Theodore T — 10% owner | Sale (S): 1,076,841 @ $0.10 | EDGAR |
| 2023-06-09 | 4 | Amin Naseem — Director | Grant/award (A): 47,578 @ $0 | EDGAR |
| 2023-06-09 | 4 | Fernandes Peter — See Remarks | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Shah Parag Suresh — VP of Business Operations | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Dekker Martin — See Remarks | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Kim Bobae — VP Reg. Affairs & Quality | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Wang Theodore T — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Cloyd Mary Ann — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Teufel Crispin — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Bruder Scott P — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Puissance Capital Management LP — 10% owner Wang Theodore T — Director, 10% owner | Sale (S): 134,421 @ $0.83 | EDGAR |
| 2023-05-22 | 4 | Kim Bobae — VP Reg. Affairs & Quality | Option exercise (M): 266 @ $7.35 · Option exercise (M): 1,022 @ $7.50 · Sale (S): 9,455 @ $10 · Option exercise (M): 266 (derivative) @ $0 · Option exercise (M): 1,022 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Wang Theodore T — Director, 10% owner Puissance Capital Management LP — 10% owner | Sale (S): 560,000 @ $9.46 | EDGAR |
| 2023-02-14 | 4 | Amin Naseem — Director | Grant/award (A): 84,000 @ $0 | EDGAR |
| 2023-02-14 | 4 | Teufel Crispin — Director | Grant/award (A): 29,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Dekker Martin — VP OF ENGINEERING & MANUFACTUR | Grant/award (A): 50,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Shah Parag Suresh — VP OF BUSINESS OPERATIONS | Grant/award (A): 50,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Fernandes Peter — CHIEF EXECUTIVE OFFICER | Grant/award (A): 100,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Laccona Nicholas — FINANCIAL OFFICER, (PFO & PAO) | Grant/award (A): 50,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Cloyd Mary Ann — Director | Grant/award (A): 29,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Wang Theodore T — Director, 10% owner | Grant/award (A): 29,000 (derivative) @ $1.52 | EDGAR |
| 2023-02-14 | 4 | Bruder Scott P — Director | Grant/award (A): 29,000 (derivative) @ $1.52 | EDGAR |
| 2022-12-13 | 4 | Dekker Martin — VP OF ENGINEERING & MANUFACTUR | Option exercise (M): 25,500 · Tax withholding (F): 7,834 @ $0.93 · Option exercise (M): 25,500 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Fernandes Peter — PRINCIPAL EXECUTIVE OFFICER | Option exercise (M): 32,500 · Tax withholding (F): 9,985 @ $0.93 · Option exercise (M): 32,500 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Shah Parag Suresh — VP OF BUSINESS OPERATIONS | Option exercise (M): 25,500 · Tax withholding (F): 7,834 @ $0.93 · Option exercise (M): 25,500 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Laccona Nicholas — FINANCIAL OFFICER, (PFO & PAO) | Option exercise (M): 18,000 · Tax withholding (F): 5,530 @ $0.93 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Fernandes Peter — CHIEF REGULATORY & SAFETY OFFR | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Dekker Martin — VP OF ENGINEERING & MANUFACTUR | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Shah Parag Suresh — VP OF BUSINESS OPERATIONS | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2022-01-28 | 4 | Laccona Nicholas — FINANCIAL OFFICER, (PFO & PAO) | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Wang Theodore T — Director, 10% owner | Grant/award (A): 21,828 (derivative) @ $3.10 | EDGAR |
| 2022-01-04 | 4 | Teufel Crispin — Director | Grant/award (A): 21,828 (derivative) @ $3.10 | EDGAR |
| 2022-01-04 | 4 | Cloyd Mary Ann — Director | Grant/award (A): 21,828 (derivative) @ $3.10 | EDGAR |
| 2022-01-04 | 4 | Amin Naseem — Director | Grant/award (A): 39,032 @ $0 · Grant/award (A): 8,671 (derivative) @ $3.10 | EDGAR |
| 2022-01-04 | 4 | Bruder Scott P — Director | Grant/award (A): 21,828 (derivative) @ $3.10 | EDGAR |
| 2021-06-08 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Puissance Capital Management LP — 10% owner Puissance Capital Management (GP) LLC — 10% owner Wang Theodore T — Director, 10% owner | Grant/award (A): 8,189 @ $4 | EDGAR |
| 2021-04-26 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Puissance Capital Management LP — 10% owner Puissance Capital Management (GP) LLC — 10% owner Wang Theodore T — Director, 10% owner | Grant/award (A): 609,231 @ $4 · Grant/award (A): 380,950 (derivative) @ $0 · Grant/award (A): 304,286 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Peacock Jonathan M — Director | Grant/award (A): 15,308 @ $0 | EDGAR |
| 2021-03-22 | 4 | New Mountain Investments II, LLC — 10% owner New Mountain Capital, L.L.C. — 10% owner KLINSKY STEVEN B — 10% owner | Sale (S): 400,000 @ $5.48 | EDGAR |
| 2020-09-14 | 4 | FARES Wassim — Chief Medical Officer | Grant/award (A): 30,000 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | Wang Theodore T — Director, 10% owner | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | Teufel Crispin — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | Moura Andre V. — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | Cloyd Mary Ann — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | Amin Naseem — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | FARES Wassim — Chief Medical Officer | Purchase (P): 4,000 @ $10.18 | EDGAR |
| 2020-09-14 | 4 | Bruder Scott P — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
| 2020-09-14 | 4 | BENNETT MATTHEW — Director | Grant/award (A): 6,509 (derivative) @ $10.12 | EDGAR |
Recent 8-K events — Bellerophon Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2024-01-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-12-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-11-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-10-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-08-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-07-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BLPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs